| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |